Clinical Chemistry Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 46: 1696-1699, 2000;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bodzioch, M.
Right arrow Articles by Schmitz, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bodzioch, M.
Right arrow Articles by Schmitz, G.
Related Collections
Right arrow Molecular Diagnostics and Genetics
(Clinical Chemistry. 2000;46:1696-1699.)
© 2000 American Association for Clinical Chemistry, Inc.

Technical Briefs

Rapid Detection of the Two Most Common CLN2 Mutations Causing Classical Late Infantile Neuronal Ceroid Lipofuscinosis

Marek Bodzioch, Charalampos Aslanidis, Marek Kacinski, Nanbert Zhong, Krystyna E. Wisniewski and Gerd Schmitz
Neuronal ceroid lipofuscinoses (NCLs) are a group of genetically transmitted neurodegenerative disorders characterized clinically by intellectual and motor decline, visual loss, and myoclonic seizures, in most cases preceded by a variable period of apparently normal development. A common pathological feature of all NCLs is the intracellular accumulation of an autofluorescent material resembling ceroid or lipofuscin. Five genes (CLN1, CLN2, CLN3, CLN5, and CLN8) have been identified that are mutated in different forms of NCL: respectively, infantile NCL (1); late infantile NCL (2)(3); classical juvenile NCL (4)(5)(6); Finnish variant late infantile NCL (7); and the progressive epilepsy with mental retardation (EPMR, also called Northern epilepsy) (8). Adult-onset NCL (CLN4) follows either an autosomal recessive (Kufs disease) or an autosomal dominant (Parry disease) pattern of inheritance and is likely to be linked to different, as yet unknown, gene loci.

The classical late infantile and juvenile forms, by far the commonest NCLs reported in different populations, are leading causes of neurodegeneration in childhood and adolescence. More than 30 mutations, scattered along the whole CLN2 gene, have been reported in association with the classical late infantile NCL (cLINCL) phenotype (9)(10). However, studies performed on large groups of cLINCL patients demonstrated that two mutations, 636C->T and T523-1G->C, are particularly common (9)(11). They occur in ~60% of cLINCL chromosomes, and at least one of these mutations can be identified in >75% of patients (12). We report here (a) successful development of a real-time multiplex fluorescence PCR with two dyes for the rapid detection of these two mutations and (b) genetic analysis of five new cLINCL families from South-Eastern Poland.

We obtained DNA . . . [Full Text of this Article]


Acknowledgments


References






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Association for Clinical Chemistry.